22157.jpg
Cell Therapy and Gene Therapy Markets, 2030
06 nov. 2020 06h28 HE | Research and Markets
Dublin, Nov. 06, 2020 (GLOBE NEWSWIRE) -- The "Cell Therapy and Gene Therapy Markets" report has been added to ResearchAndMarkets.com's offering. The report examines developments in cell and gene...
22157.jpg
Whole Genome And Exome Sequencing Markets, 2023
07 oct. 2020 02h04 HE | Research and Markets
Dublin, Oct. 07, 2020 (GLOBE NEWSWIRE) -- The "Whole Genome And Exome Sequencing Markets - By Research, Clinical, Direct to Consumer, AgriBio & Tumor with Executive and Consultant Guides 2020 to...
®_Bionano_RGB.jpg
Bionano Genomics Launches New Capabilities of the Saphyr System to Significantly Increase Its Cost Effectiveness, Speed and Ease of Use for Whole Human Genome Structural Variation Analysis and Digital Cytogenetics
01 mars 2019 08h00 HE | Bionano Genomics
SAN DIEGO, March 01, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and...
®_Bionano_RGB.jpg
Global Adoption of Bionano Genomics’ Saphyr® System Accelerating for Clinical Genomics Applications
14 janv. 2019 08h00 HE | Bionano Genomics
SAN DIEGO, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets the Saphyr system, which enables ultra-sensitive...
®_Bionano_RGB.jpg
UPDATE – GrandOmics Biosciences Offers Genetic Test Using the Saphyr System for Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy (FSHD) in China
19 oct. 2018 20h51 HE | Bionano Genomics; GrandOmics Biosciences
SAN DIEGO, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and...
®_Bionano_RGB.jpg
Bionano Genomics’ Structural Variation Results Presented at ASHG 2018 Provide Insights in Cancer and Genetic Disease
16 oct. 2018 15h00 HE | Bionano Genomics
SAN DIEGO, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and...